Repurposing of World-Approved Drugs for Potential Inhibition against Human Carbonic Anhydrase I: A Computational Study
Human carbonic anhydrases (hCAs) have enzymatic activities for reversible hydration of CO<sub>2</sub> and are acknowledged as promising targets for the treatment of various diseases. Using molecular docking and molecular dynamics simulation approaches, we hit three compounds of methyl 4-...
Main Authors: | Nannan Zheng, Wanyun Jiang, Puyu Zhang, Le Ma, Junzhao Chen, Haiyang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/16/12619 |
Similar Items
-
Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation
by: Wanyun Jiang, et al.
Published: (2023-10-01) -
Drug Repurposing of the Unithiol: Inhibition of Metallo-β-Lactamases for the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections
by: Vitaly G. Grigorenko, et al.
Published: (2022-02-01) -
Repurposing of the Drug Tezosentan for Cancer Therapy
by: Eduarda Ribeiro, et al.
Published: (2023-06-01) -
Playing with Structural Parameters: Synthesis and Characterization of Two New Maltol-Based Ligands with Binding and Antineoplastic Properties
by: Eleonora Macedi, et al.
Published: (2020-02-01) -
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1
by: Emanuele Criscuolo, et al.
Published: (2023-12-01)